The bidirectional flyback-based active cell balancing approach offers a compact and scalable solution for modern multicell ...
Sanofi has struck an exclusive rights deal with Dutch biotech Kiadis focused on combining modified natural killer cells with the French pharma’s blood cancer antibody Sarclisa. Sarclisa (isatuximab) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback